Yun-Ju Woo

Title: Innovations of Yun-Ju Woo in Autoimmune Disease Treatment.

Introduction

Yun-Ju Woo is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. His innovative approach focuses on enhancing the therapeutic efficacy of dendritic cells.

Latest Patents

Yun-Ju Woo holds a patent for a method that prepares dendritic cells with increased specific gene expression. The patent, titled "Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same," addresses the generation of semi-mature dendritic cells. This method involves treating immature dendritic cells with auto-antigens, cytokines, and PGE2, specifically targeting rheumatoid arthritis. The invention demonstrates that the levels of NR4A2 and/or UBASH3B at gene or protein levels can be increased more than two-fold compared to immature dendritic cells. Furthermore, it introduces a cell therapeutic agent for treating or preventing autoimmune diseases, which contains the semi-mature dendritic cells as an active ingredient.

Career Highlights

Yun-Ju Woo is associated with Jw Creagene Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment landscape for autoimmune diseases, particularly rheumatoid arthritis.

Collaborations

Yun-Ju Woo collaborates with esteemed colleagues, including Yong-Soo Bae and Jun-Eui Park. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Yun-Ju Woo's innovative methods in preparing dendritic cells represent a promising advancement in the treatment of autoimmune diseases. His contributions are paving the way for more effective therapies in the medical field.